This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ Spinacia oleracea {Spinach}

AI Engines For more Details: Perplexity  Kagi Labs  You 

Check for interactions on Supp.AI   |   📚 PubMed Citations

Data Contradictions — Limits of Certainity

Impacted of Spinacia oleracea {Spinach} On Probiotics

Rank Probiotic Impact
species Lactobacillus acidophilus Increases
species Lactobacillus crispatus Increases
species Lactobacillus gasseri Increases
species Lactobacillus helveticus Increases
species Lactobacillus jensenii Increases
species Lactobacillus johnsonii Increases
species Lactobacillus kefiranofaciens Increases
species Limosilactobacillus reuteri Increases

Bacteria Impacted by Spinacia oleracea {Spinach}

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 2 Lactobacillaceae family Increases
0 1 Limosilactobacillus genus Increases
2 0 Lactobacillus genus Increases
0 2 environmental samples no rank Increases
0 2 unclassified Lactobacillus no rank Increases
0 2 Lactobacillus ultunensis species Increases
0 2 Lactobacillus helveticus species Increases
0 2 Lactobacillus johnsonii species Increases
0 2 Lactobacillus kefiranofaciens species Increases
0 2 Lactobacillus amylolyticus species Increases
0 2 Lactobacillus acetotolerans species Increases
0 2 Lactobacillus amylovorus species Increases
0 2 Lactobacillus iners species Increases
0 2 Lactobacillus taiwanensis species Increases
0 2 Lactobacillus crispatus species Increases
0 2 Lactobacillus intestinalis species Increases
0 2 Lactobacillus acidophilus species Increases
0 2 Lactobacillus paragasseri species Increases
0 2 Lactobacillus jensenii species Increases
0 2 Lactobacillus gasseri species Increases
0 2 [Lactobacillus] rogosae species Increases
0 2 Lactobacillus alvei species Increases
0 2 Lactobacillus animata species Increases
0 2 Lactobacillus apis species Increases
0 2 Lactobacillus bombicola species Increases
0 2 Lactobacillus brevisimilis species Increases
0 2 Lactobacillus equicursoris species Increases
0 2 Lactobacillus faeni species Increases
0 2 Lactobacillus fornicalis species Increases
0 2 Lactobacillus gallinarum species Increases
0 2 Lactobacillus gigeriorum species Increases
0 2 Lactobacillus guizhouensis species Increases
0 2 Lactobacillus hamsteri species Increases
0 2 Lactobacillus helsingborgensis species Increases
0 2 Lactobacillus hominis species Increases
0 2 Lactobacillus intermedius species Increases
0 2 Lactobacillus japonicus species Increases
0 2 Lactobacillus kalixensis species Increases
0 2 Lactobacillus kitasatonis species Increases
0 2 Lactobacillus kullabergensis species Increases
0 2 Lactobacillus leichmannii species Increases
0 2 Lactobacillus letivazi species Increases
0 2 Lactobacillus mulieris species Increases
0 2 Lactobacillus panisapium species Increases
0 2 Lactobacillus pasteurii species Increases
0 2 Lactobacillus psittaci species Increases
0 2 Lactobacillus rodentium species Increases
0 2 Lactobacillus selangorensis species Increases
0 2 Lactobacillus terrae species Increases
0 2 Lactobacillus delbrueckii species Increases
1 0 Limosilactobacillus reuteri species Increases
0 2 Lactobacillus casei group species group Increases
0 1 Limosilactobacillus reuteri subsp. murium subspecies Increases
0 1 Limosilactobacillus reuteri subsp. reuteri subspecies Increases
0 1 Limosilactobacillus reuteri subsp. rodentium subspecies Increases
0 1 Limosilactobacillus reuteri subsp. suis subspecies Increases

Impact of Spinacia oleracea {Spinach} on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.8 0.8
ADHD 0.6 0.6
Allergic Rhinitis (Hay Fever) 0.7 0.7
Allergies 1 1.4 -0.4
Alzheimer's disease 0.2 0.6 -2
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.6 -0.6
Ankylosing spondylitis 0.8 0.8
Asthma 0.8 0.6 0.33
Atherosclerosis 0.6 -0.6
Atrial fibrillation 0.6 -0.6
Autism 1.2 0.8 0.5
Autoimmune Disease 0.7 0.7
Brain Trauma 0.6 0.6
Cancer (General) 1.2 1.2
Carcinoma 0.6 -0.6
Celiac Disease 0.6 0.6 0
Chronic Fatigue Syndrome 0.6 0.6
Chronic Kidney Disease 0.8 0.8
Chronic Obstructive Pulmonary Disease (COPD) 0.6 -0.6
Cognitive Function 0.8 0.8 0
Colorectal Cancer 0.6 0.8 -0.33
Constipation 0.6 0.6
Coronary artery disease 0.6 0.6
COVID-19 1.2 0.6 1
Crohn's Disease 0.6 0.6 0
d-lactic acidosis (one form of brain fog) 1.6 -1.6
Denture Wearers Oral Shifts 0.6 0.6
Depression 1.4 1.7 -0.21
Eczema 0.2 0.2
Endometriosis 0.9 0.6 0.5
Epilepsy 0.6 0.6
Fibromyalgia 0.6 0.6 0
Functional constipation / chronic idiopathic constipation 0.6 0.6
gallstone disease (gsd) 0.6 0.2 2
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.8 0.8
Graves' disease 0.6 0.6 0
Hashimoto's thyroiditis 0.8 0.8
Heart Failure 0.6 0.6 0
High Histamine/low DAO 0.6 -0.6
hypercholesterolemia (High Cholesterol) 0.6 0.6
hyperglycemia 0.6 0.6
Hyperlipidemia (High Blood Fats) 0.8 0.8
hypertension (High Blood Pressure 0.6 0.6 0
Hypoxia 0.6 0.6 0
IgA nephropathy (IgAN) 0.6 0.6
Inflammatory Bowel Disease 0.8 0.6 0.33
Insomnia 0.2 0.7 -2.5
Intracranial aneurysms 0.6 0.6
Irritable Bowel Syndrome 0.6 0.6 0
ischemic stroke 0.6 -0.6
Liver Cirrhosis 0.8 0.6 0.33
Long COVID 0.6 0.8 -0.33
ME/CFS with IBS
ME/CFS without IBS
Menopause 0.7 0.7
Metabolic Syndrome 1.2 0.8 0.5
Mood Disorders 0.8 1.9 -1.37
multiple chemical sensitivity [MCS] 0.6 -0.6
Multiple Sclerosis 1 0.6 0.67
Multiple system atrophy (MSA) 0.6 -0.6
neuropathic pain 0.6 0.6
Neuropathy (all types) 0.6 -0.6
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.6 0.8 -0.33
NonCeliac Gluten Sensitivity 0.6 0.6
Obesity 0.9 1.2 -0.33
obsessive-compulsive disorder 0.6 0.6 0
Osteoporosis 0.6 0.6 0
Parkinson's Disease 1.4 1 0.4
Polycystic ovary syndrome 0.9 0.6 0.5
primary biliary cholangitis 0.6 -0.6
Primary sclerosing cholangitis 0.6 -0.6
Psoriasis 0.1 0.6 -5
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.4 0.8 0.75
Rosacea 0.6 0.6
Schizophrenia 0.8 1 -0.25
Sjögren syndrome 0.2 -0.2
Slow gastric motility / Gastroparesis 0.6 0.6
Small Intestinal Bacterial Overgrowth (SIBO) 0.6 -0.6
Stress / posttraumatic stress disorder 0.6 -0.6
Systemic Lupus Erythematosus 0.8 0.6 0.33
Tourette syndrome 0.6 0.6
Type 1 Diabetes 0.6 0.6 0
Type 2 Diabetes 0.6 0.8 -0.33
Ulcerative colitis 0.8 0.8 0
Unhealthy Ageing 0.7 0.6 0.17

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]